Jun 25 2010
Biotechnology company Dyadic International, Inc. has selected consulting company The Abraham Group for providing transactional assistance and strategic advice to Dyadic International, even as it actively seeks licensing deals and other strategic partnerships throughout the globe.
Dyadic International’s C1 platform technology meets the requirements of the biofuels industry by producing industry-scale enzymes that transform biomass into ethanol as well as other alternative energy resources.
Using the C1 platform technology, cost-effective alternatives to petroleum-based products and oil can be produced. More than ten years of research and development efforts have gone into the C1 platform technology, which can be programmed to generate novel commercial-scale, cost-effective enzymes even under different operating conditions. These enzymes offer enhanced flexibility in processing different biomass types by biorefineries into sugars that are fermentable, which can be transformed into biofuels including butanol and ethanol in addition to polymers, plastics and chemicals.
Previously, Dyadic International has licensed the C1 platform technology to Abengoa Bioenergy, a biofuels and energy producer, in the biofuels area. The company also licensed the technology to Codexis. Dyadic International and these licenses continue to make improvements on the C1 platform technology in an effort to make production methods more efficient in generating low-cost biofuels at large quantities.
Source: http://www.dyadic.com/